Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Founded in 1989, Medis Medical Imaging Systems B.V. provides high-quality quantitative analysis solutions for cardiovascular imaging to the medical community. Medis’ software is internationally appreciated due to its ease of use and clinical outcomes for patients. The company continuously focuses on creating, researching and innovating towards clinically relevant software solutions in the field of cardiovascular imaging.

Oaklins’ team in the Netherlands acted as the exclusive strategic advisor to the shareholders and management of Medis Medical Imaging Systems B.V.

Services

Conseil en financement par dette ou en équité

Parties prenantes

«We are delighted to be taking this next step with GE HealthCare, a fellow leader in the interventional cardiology domain. Building on Medis QFR’s decade of AI research, customer-focused product development, clinical evidence generation and business development, we are excited to be able to further accelerate our efforts around Medis QFR to enable more hospitals and clinicians to apply physiology in day-to-day interventional practice as part of clinical care best practices, making this technology more accessible and available to patients than ever before.»

Maya Barley

CEO, Medis Medical Imaging Systems B.V.

Contacter l'équipe de la transaction

Martijn de Win

Directeur

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Robert Boersma

Associé

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Robbert Bon

Analyste principal

Amsterdam, Pays-Bas
Oaklins Netherlands

Voir le profil Entrer en contact

Transactions connexes

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Soins de la Santé

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

En apprendre plus

Outsource Management Services has been acquired by IMI Supply Chain Solutions

Logistique | TMT

Outsource Management Services has been acquired by IMI Supply Chain Solutions

UK logistics software provider Outsource Management Services (OMS) has been acquired by IMI Supply Chain Solutions, a Sweden-based provider of supply chain management software solutions.

En apprendre plus

EuroHospital Varna has been acquired by Intermedica Group

Soins de la Santé

EuroHospital Varna has been acquired by Intermedica Group

EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.

En apprendre plus